Back to Peptide Database
DermatologyResearch Phase

Trylagen (Tripeptide-10 Complex)

Overview

Trylagen is a proprietary complex incorporating Tripeptide-10 Citrulline along with additional bioactive peptides formulated to support collagen and elastin network architecture. The complex aims to influence multiple stages of extracellular matrix synthesis and assembly, including fibroblast proliferation, procollagen processing, and elastin fiber organization. The therapeutic rationale is directed toward comprehensive photoaging correction and improvement of skin firmness.

Key Research Findings

Preclinical studies have reported increased expression of collagen I, collagen III, and fibrillin in fibroblast cultures and organotypic skin models. Published clinical trial evidence in indexed dermatology journals remains sparse, with available data largely derived from manufacturer-led assessments of skin elasticity and wrinkling.

Route of Administration

Topical

Regulatory Status

Research Phase

Interested in Trylagen (Tripeptide-10 Complex)?

Find a verified provider experienced with Trylagen (Tripeptide-10 Complex) protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Trylagen (Tripeptide-10 Complex) Provider

Related Peptides

Afamelanotide (Scenesse)

FDA Approved

A synthetic 13-amino acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with a substitution of norleucine at position 4 that confers enhanced potency and enzymatic stability. Afamelanotide activates melanocortin-1 receptors (MC1R) on melanocytes, stimulating eumelanin production independent of UV exposure. The resulting increase in skin eumelanin provides photoprotection by absorbing UV radiation and scavenging reactive oxygen species.

Argireline (Acetyl Hexapeptide-8)

Investigational

Argireline is a synthetic six amino acid peptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) designed to attenuate neurotransmitter release at the neuromuscular junction. It functions as a competitive inhibitor of the SNARE complex, reducing catecholamine release and potentially diminishing muscle contraction intensity in facial expression muscles. This mechanism provides a topical alternative rationale to botulinum toxin for addressing expression lines, though with markedly lower potency.

Matrixyl (Palmitoyl Pentapeptide-4)

Investigational

Matrixyl is a lipopeptide composed of a pentapeptide sequence (Lys-Thr-Thr-Lys-Ser) attached to a palmitic acid moiety to enhance dermal penetration. It is proposed to stimulate fibroblast activity and upregulate synthesis of extracellular matrix components including collagen types I and III, fibronectin, and hyaluronic acid. The peptide serves as a matrikine fragment mimetic, signaling tissue remodeling pathways in aged or photodamaged skin.

Matrixyl 3000

Investigational

Matrixyl 3000 is a proprietary combination of two lipopeptides: palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The formulation is designed to synergistically promote collagen and fibronectin synthesis while reducing interleukin-6 mediated inflammation in dermal fibroblasts. Both peptides carry palmitic acid for enhanced lipid solubility and stratum corneum permeation.